[MAXIS] QoQ Cumulative Quarter Result on 31-Mar-2015 [#1]

Announcement Date
27-Apr-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- -76.14%
YoY- -15.29%
Quarter Report
View:
Show?
Cumulative Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 8,601,000 6,425,000 4,259,000 2,149,000 8,389,000 6,266,000 4,201,000 61.02%
PBT 2,460,000 1,787,000 1,221,000 590,000 2,436,000 1,934,000 1,291,000 53.51%
Tax -713,000 -510,000 -366,000 -178,000 -711,000 -544,000 -352,000 59.88%
NP 1,747,000 1,277,000 855,000 412,000 1,725,000 1,390,000 939,000 51.09%
-
NP to SH 1,739,000 1,271,000 851,000 410,000 1,718,000 1,379,000 930,000 51.60%
-
Tax Rate 28.98% 28.54% 29.98% 30.17% 29.19% 28.13% 27.27% -
Total Cost 6,854,000 5,148,000 3,404,000 1,737,000 6,664,000 4,876,000 3,262,000 63.82%
-
Net Worth 4,197,586 4,061,183 3,991,415 4,472,727 4,726,375 4,946,413 5,100,000 -12.14%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div 1,499,137 1,128,106 753,097 372,727 3,000,873 1,798,695 1,200,000 15.94%
Div Payout % 86.21% 88.76% 88.50% 90.91% 174.67% 130.43% 129.03% -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 4,197,586 4,061,183 3,991,415 4,472,727 4,726,375 4,946,413 5,100,000 -12.14%
NOSH 7,495,689 7,520,710 7,530,973 7,454,545 7,502,183 7,494,565 7,500,000 -0.03%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 20.31% 19.88% 20.08% 19.17% 20.56% 22.18% 22.35% -
ROE 41.43% 31.30% 21.32% 9.17% 36.35% 27.88% 18.24% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 114.75 85.43 56.55 28.83 111.82 83.61 56.01 61.09%
EPS 23.20 16.90 11.30 5.50 22.90 18.40 12.40 51.66%
DPS 20.00 15.00 10.00 5.00 40.00 24.00 16.00 15.99%
NAPS 0.56 0.54 0.53 0.60 0.63 0.66 0.68 -12.10%
Adjusted Per Share Value based on latest NOSH - 7,454,545
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 109.82 82.03 54.38 27.44 107.11 80.00 53.64 61.02%
EPS 22.20 16.23 10.87 5.23 21.94 17.61 11.87 51.62%
DPS 19.14 14.40 9.62 4.76 38.32 22.97 15.32 15.95%
NAPS 0.5359 0.5185 0.5096 0.5711 0.6035 0.6316 0.6512 -12.15%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 6.80 6.55 6.37 7.19 6.85 6.48 6.75 -
P/RPS 5.93 7.67 11.26 24.94 6.13 7.75 12.05 -37.58%
P/EPS 29.31 38.76 56.37 130.73 29.91 35.22 54.44 -33.74%
EY 3.41 2.58 1.77 0.76 3.34 2.84 1.84 50.70%
DY 2.94 2.29 1.57 0.70 5.84 3.70 2.37 15.40%
P/NAPS 12.14 12.13 12.02 11.98 10.87 9.82 9.93 14.29%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 04/02/16 28/10/15 15/07/15 27/04/15 06/02/15 13/11/14 22/07/14 -
Price 6.15 6.65 6.52 7.13 6.99 6.90 6.74 -
P/RPS 5.36 7.78 11.53 24.73 6.25 8.25 12.03 -41.57%
P/EPS 26.51 39.35 57.70 129.64 30.52 37.50 54.35 -37.95%
EY 3.77 2.54 1.73 0.77 3.28 2.67 1.84 61.10%
DY 3.25 2.26 1.53 0.70 5.72 3.48 2.37 23.35%
P/NAPS 10.98 12.31 12.30 11.88 11.10 10.45 9.91 7.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment